IL6 and COVID-19: Sabbatinelli et al. [140] showed that COVID-19 patients presented increased IL-6 levels and reduced miR-146a-5p levels compared to healthy age-matched subjects, pointing out the imbalance in the IL-6/miR-146a-5p physiological axis in the pathogenesis of SARS-CoV-2 infection [140].